Pathological effects of avian influenza virus antigens (H9N2 subgroup) using a chicken embryo model

Document Type : Original Article

Authors
1 Department of Pathobiology, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman- Iran.
2 Department of Animal Science, Faculty of Agriculture, University of Kurdistan, Sanandaj, Kurdistan- Iran.
3 Department of Pathobiology, Faculty of Veterinary Medicine, Amol University of Special Modern Technologies, Amol- Iran
4 Department of Pathobiology, Faculty of Veterinary Medicine, Amol University of Special Modern Technologies, Amol- Iran.
10.22034/ijvcs.2025.15134.1131
Abstract
The H9N2 subtype of influenza virus is prevalent not only across various regions in Iran but also poses a zoonotic risk, capable of transmission from birds to humans. This makes it a potential candidate for future pandemic outbreaks. The present study was aimed to investigated the pathological effects of avian influenza virus antigens (H9N2 subgroup) on the chicken embryo. Accordingly, the antigenic extracts of the H9N2 virus at a dose of 106 EID50/ml were injected into commercial fertilized eggs to assess the pathological effects on developing embryos. The findings indicated significant adverse impacts on embryonic weight and growth throughout development, notably reducing parameters associated with embryonic mass and growth rates (P<0.05). Severe pathological effects were observed in the brain and liver tissues of the embryos. This study suggests that the indigenous H9N2 subtype in Iran can cause extensive pathological impacts on developing embryos. Further studies are needed to investigate the molecular and cellular mechanisms through which the H9N2 influenza antigen affects embryonic development.
Keywords
Subjects

1.     Abdel Hamid H, Ellakany H, Hussien H, El-Bestawy A, Abdel Baky K. Pathogenicity of an Avian Influenza H9N2 Virus isolated From Broiler Chickens in Egypt. Alex J Vet Sci. 2016; 51(2).
2.     Abdelwhab EM, Abdel-Moneim AS. Orthomyxoviruses. Recent Adv Anim Virol. 2019: 351-78.
3.     Alizadeh E, Kheiri M, Bashar R, Tabatabaeian M, Hosseini SM, Mazaheri V. Avian Influenza (H9N2) among poultry workers in Iran. Iran J Microbiol. 2009; 1(3): 3-6.
4.     Aslam R, Aslam A, Tipu Y, Nazir J, Ghafoor A, Fatima S. Histopathological and immunohistochemical studies for the pathogenesis of a low pathogenicity H9 avian influenza virus in experimentally infected commercial broilers. JAPS: J Anim Plant Sci. 2015; 25(1).
5.     Bashashati M, Chung DH, Fallah Mehrabadi MH, Lee DH. Evolution of H9N2 avian influenza viruses in Iran, 2017–2019. Transbound Emerg Dis. 2021; 68(6): 3405-3414.
6.     Begum JA, Hossain I, Nooruzzaman M, King J, Chowdhury EH, Harder TC, et al. Experimental pathogenicity of H9N2 avian influenza viruses harboring a tri-basic hemagglutinin cleavage site in Sonali and broiler chickens. Viruses. 2023; 15(2): 461.
7.     Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol. 2021; 93(8): 4638-4646.
8.     Jin H, Wang W, Yang X, Su H, Fan J, Zhu R, et al. Evolution of H9N2 avian influenza virus in embryonated chicken eggs with or without homologous vaccine antibodies. BMC Vet Res. 2018; 14: 1-11.
9.     Parija SC. Orthomyxoviruses. In: Textbook of Microbiology and Immunology. Springer; 2023. p. 797-809.
10.  Pleschka S. Overview of influenza viruses. Swine influenza. 2012: 1-20.
11.  Pu J, Wang S, Yin Y, Zhang G, Carter RA, Wang J, et al. Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proc Natl Acad Sci. 2015; 112(2): 548-53.
12.  Rozek W, Kwasnik M, Socha W, Sztromwasser P, Rola J. Analysis of Single Nucleotide Variants (SNVs) Induced by Passages of Equine Influenza Virus H3N8 in Embryonated Chicken Eggs. Viruses. 2021; 13(8): 1551.
13.  Tare DS, Pawar SD. Use of embryonated chicken egg as a model to study the susceptibility of avian influenza H9N2 viruses to oseltamivir carboxylate. J Virol Methods. 2015; 224: 67-72.
14.  Webster RG. Influenza: an emerging disease. Emerg Infect Dis. 1998; 4(3): 436.